Diversify With These Health ETFs
The FDA recently approved higher-dose version of Novo Nordisk’s NVO obesity drug Wegovy, further expanding the drug giant’s footprint in…
Why the weight-loss drugs battle will intensify in 2026, explained in 5 charts
Novo executives project that oral pills could capture more than a third of the total obesity drug market…